Biodexa Pharmaceuticals
BDRX | NASDAQ
$2.80
-$0.63 (-18.37%)
At close: Nov 2, 2026, 4:00 PM ET
$2.80
$0.00 (0.00%)
After-hours:
Nov 2, 2026, 4:34 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -210.59 | -436.67 | -378.25 | -682.75 | -3.33K | -824.26 |
PEG Ratio | 2.36 | 4.61 | 3.84 | -291.75 | 38.72 | 153.40 |
PS Ratio | n/a | n/a | 8.73K | 9.21K | 43.24K | 68.38K |
PB Ratio | 162.36 | 385.21 | 711.40 | 2.04K | 2.39K | 3.49K |
P/FCF Ratio | -342.56 | -245.93 | -469.45 | -905.55 | -3.95K | -2.47K |
P/OCF Ratio | -342.69 | -261.46 | -487.54 | -913.52 | -4.16K | -2.52K |
OCF/S Ratio | n/a | n/a | -1.79K | -1.01K | -1.04K | -2.71K |
Debt / Equity Ratio | 0.01 | 0.09 | 0.10 | 0.20 | 0.07 | 0.04 |
Quick Ratio | 2.03 | 1.75 | 1.39 | 2.47 | 6.39 | 3.10 |
Current Ratio | 2.03 | 1.75 | 1.26 | 2.47 | 6.39 | 3.10 |
Asset Turnover | n/a | n/a | 0.04 | 0.13 | 0.04 | 0.03 |
Interest Coverage | -120.77 | n/a | -195.46 | -168.53 | -159.05 | -677.65 |
Return on Equity | -54.85% | -68.84% | -151.33% | -242.13% | -52.24% | -330.29% |
Return on Assets | -34.41% | -38.76% | -67.15% | -138.57% | -42.28% | -226.03% |
Return on Invested Capital | -67.29% | -85.12% | -147.40% | -212.80% | -55.78% | -309.94% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | -967.45% | -631.19% | -705.19% | -1.67K% |
Net Profit Margin | n/a | n/a | -1.86K% | -1.1K% | -944.64% | -6.47K% |
Pretax Profit Margin | n/a | n/a | -1.96K% | -1.21K% | -1.06K% | -6.84K% |
Operating Profit Margin | n/a | n/a | -2.1K% | -1.28K% | -1.21K% | -6.72K% |
FCF Margin | n/a | n/a | -1.86K% | -1.02K% | -1.09K% | -2.77K% |
EBITDA Margin | n/a | n/a | -1.88K% | -1.16K% | -979.07% | -6.48K% |
Add to Watchlist
Select watchlists to add or remove BDRX